Camp4 Therapeutics Corporation
CAMP
$9.33
$0.303.32%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -13.48M | -12.51M | -12.51M | -11.70M | |
| Total Depreciation and Amortization | 418.00K | 430.00K | 430.00K | 430.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 2.06M | 1.26M | 1.26M | 1.13M | |
| Change in Net Operating Assets | 1.31M | -1.47M | -1.47M | 3.59M | |
| Cash from Operations | -9.69M | -12.29M | -12.29M | -6.55M | |
| Capital Expenditure | 0.00 | -89.00K | -89.00K | -207.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | 0.00 | -89.00K | -89.00K | -207.00K | |
| Total Debt Issued | -- | -- | -- | 0.00 | |
| Total Debt Repaid | -205.00K | -204.00K | -204.00K | -204.00K | |
| Issuance of Common Stock | 31.00K | 1.00K | 1.00K | 1.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -212.00K | -304.00K | -304.00K | -- | |
| Cash from Financing | -386.00K | -507.00K | -507.00K | -203.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -10.08M | -12.89M | -12.89M | -6.96M | |
